🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to document the safety of tecemotide (L-BLP25) pha...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00157196
Treatments Being Tested
This study is designed as Phase II/III. Phase II is aimed to evaluate safet...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2019-06-19
Trial ID
NCT03992911
Treatments Being Tested
Cancer patients with known or newly diagnosed (i.e. iatrogenic) Diabetes Me...
Status
Unknown
Location
Palliative care Service - Sheba Medical Centre
Start Date
2021-06-30
Trial ID
NCT04942756
Treatments Being Tested
Cytoreductive surgery (CRS) with the addition of hyperthermic intraperitone...
Status
Active Not Recruiting
Location
Antoni van Leeuwenhoek (NKI-AVL)
Start Date
2022-06-15
Trial ID
NCT05406674
Treatments Being Tested
The purpose of this study is to determine the most effective treatment opti...
Status
Completed
Location
Alberta Children's Hospital
Start Date
2003-08
Trial ID
NCT00706693
Treatments Being Tested
The purpose of this study is to assess the efficacy and toxicity of pemetre...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2006-11
Trial ID
NCT00380718
Treatments Being Tested
This is an open-label, non-randomized, multicenter Phase II study evaluatin...
Status
Completed
Location
Research Site
Start Date
2009-02
Trial ID
NCT00778830
EMD Serono has decided to permanently terminate the trial EMR 200038-010 (S...
Status
Terminated
Location
Research Site
Start Date
2009-09
Trial ID
NCT00925548
To validate the ability of the FatHealth algorithm to identify individuals ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02-15
Trial ID
NCT05058690
Treatments Being Tested
Diarrhoea is the most commonly reported adverse event (AE) associated with ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-12-17
Trial ID
NCT02294786
Treatments Being Tested